###begin article-title 0
A Cajal body-specific pseudouridylation guide RNA is composed of two box H/ACA snoRNA-like domains
###end article-title 0
###begin p 1
###xml 235 256 235 256 <email xmlns:xlink="http://www.w3.org/1999/xlink">tamas@ibcg.biotoul.fr</email>
To whom correspondence should be addressed at Laboratoire de Biologie Moleculaire Eucaryote du CNRS, Universite Paul Sabatier, 118 route de Narbonne, 31062 Toulouse Cedex, France. Tel: +33 5 61 33 59 91; Fax: +33 5 61 33 58 86; Email: tamas@ibcg.biotoul.fr
###end p 1
###begin p 2
###xml 566 571 <span type="species:ncbi:9606">human</span>
Site-specific post-transcriptional conversion of uridines to pseudouridine in ribosomal RNAs and small nuclear RNAs (snRNAs) is directed by guide RNAs which possess the conserved box H and ACA sequence elements and fold into the consensus 'hairpin-hinge-hairpin-tail' secondary structure. Here, we describe an unusual mammalian pseudouridylation guide RNA, called U93, that is composed of two tandemly arranged box H/ACA RNA domains. The U93 RNA therefore carries two H and two ACA box motifs, all of which are essential for accumulation of the full-length RNA. The human U93 RNA accumulates in Cajal (coiled) bodies and it is predicted to function in pseudouridylation of the U2 spliceosomal snRNA. Our results lend further support to the notion that modification of the RNA polymerase II-transcribed spliceosomal snRNAs takes place in Cajal bodies.
###end p 2
###begin p 3
DDBJ/EMBL/GenBank accession no. AF492209
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 109 110 109 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c1">1</xref>
###xml 477 478 477 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c2">2</xref>
###xml 610 611 610 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c3">3</xref>
###xml 612 613 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c4">4</xref>
###xml 679 680 679 680 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c5">5</xref>
###xml 812 813 812 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c1">1</xref>
The nucleus contains a large number of small nuclear RNAs (snRNAs) which possess diverse cellular functions (1). The U1, U2, U4, U5 and U6 spliceosomal snRNAs play a pivotal role in the removal of intron regions from pre-mRNAs. The U7 snRNA directs 3'-end formation of histone mRNAs and the RNase P RNA functions in 5'-end processing of tRNAs. The U3, U8, U14, U22, snR30 and MRP small nucleolar RNAs (snoRNAs) are required for the production of mature ribosomal RNAs (rRNAs) (2). Besides RNA processing, snRNAs also function in the regulation of transcription elongation by RNA polymerase (pol) II (7SK RNA) (3,4) and in the synthesis of telomeric DNA repeats (telomerase RNA) (5). All snRNAs associate with specific proteins and form small nuclear or nucleolar ribonucleoprotein particles (snRNPs or snoRNPs) (1).
###end p 5
###begin p 6
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c6">6</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c11">11</xref>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f1">1</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c12">12</xref>
###xml 565 567 565 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c13">13</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c14">14</xref>
###xml 740 742 740 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c15">15</xref>
###xml 916 917 916 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1155 1156 1155 1156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c8">8</xref>
###xml 1157 1159 1157 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c10">10</xref>
###xml 1526 1527 1526 1527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 1616 1618 1616 1618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c16">16</xref>
###xml 1619 1621 1619 1621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c17">17</xref>
The nucleus also contains an enormous number of modification guide RNAs which direct the post-transcriptional synthesis of 2'-O-methylated nucleotides and pseudouridines in rRNAs, spliceosomal snRNAs and, most likely, other cellular RNAs (for recent reviews, see 6-11). The 2'-O-methylation guide RNAs possess the conserved box C (RUGAUGA) and D (CUGA) elements that are frequently tethered by a short 5',3'-terminal stem (Fig. 1). The internal region of box C/D RNAs carries the C' and D' boxes which represent perfect or imperfect copies of the C and D boxes (12,13). The pseudouridylation guide RNAs are characterised by a consensus 'hairpin-hinge-hairpin-tail' structure and they carry the conserved H (ANANNA) and ACA box elements (14,15). The H box is located in the single-stranded hinge region after the 5' hairpin. The ACA box is found in the 3'-terminal tail 3 nt before the end of the RNA. The box C/D 2'-O-methylation guide RNAs are associated with four RNP proteins, fibrillarin/Nop1p, Nop56p, Nop58p and 15.5kD/Snu13p, whereas the box H/ACA pseudouridylation guide RNAs specifically bind dyskerin/Cbf5p, Gar1p, Nhp2p and Nop10p (reviewed in 8-10). The guide RNAs provide scaffolding for the associated RNP proteins and select the target nucleotide by forming direct base-pairing interactions with the substrate RNA. In turn, the RNP proteins provide metabolic stability for the guide RNAs and catalyse the modification reactions. Most likely, the fibrillarin/Nop1p and dyskerin/Cbf5p RNP proteins perform the 2'-O-methyl transfer and the uridine to pseudouridine isomerisation reactions, respectively (16,17).
###end p 6
###begin p 7
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c2">2</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 271 272 271 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 317 319 317 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c19">19</xref>
###xml 320 322 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c23">23</xref>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c24">24</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c26">26</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 493 495 493 495 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
The modification guide RNAs accumulate either in the nucleolus or in the Cajal body and, accordingly, they are called snoRNAs or small Cajal body-specific RNAs (scaRNAs) (2,18). The two groups of modification guide RNAs possess different functions. The snoRNAs direct 2'-O-methylation and pseudouridylation of rRNAs (19-23) and the RNA pol III-transcribed U6 spliceosomal snRNA (24-26). The scaRNAs function in modification of the RNA pol II-specific U1, U2, U4 and U5 spliceosomal snRNAs (18,27).
###end p 7
###begin p 8
###xml 87 88 87 88 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f1">1</xref>
###xml 123 124 123 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
###xml 361 366 <span type="species:ncbi:9606">human</span>
###xml 368 373 <span type="species:ncbi:10090">mouse</span>
###xml 378 381 <span type="species:ncbi:9913">cow</span>
The scaRNAs are frequently composed of a box C/D and a box H/ACA RNA-like domain (Fig. 1) and they can function both in 2'-O-methylation and pseudouridylation of snRNAs (18,27). Here, we describe a novel mammalian scaRNA, called the U93 RNA, that is predicted to function in pseudouridylation of the RNA pol II-specific U2 spliceosomal snRNA. Surprisingly, the human, mouse and cow U93 scaRNAs are composed of two tandemly repeated box H/ACA domains and therefore they contain two H and two ACA boxes which are all essential for accumulation of the full-length U93 RNA.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
General procedures
###end title 10
###begin p 11
###xml 127 132 127 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 135 137 135 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c28">28</xref>
Unless stated otherwise, all techniques for manipulating DNA, RNA and oligonucleotides have been done as described by Sambrook et al. (28). The following oligonucleotides were used in this study: 1, ATGCCTCAGCTTCCTCT; 2, CAG ACTTGCAGAAAAAGCA; 3, CAGTACTTAGTGTTCAA CAGA; 4, ATAATCGATAATCTGTAGTCTTGGAGCCGC; 5, ATAGTCGACACTTGTGGCAGTACTTAGTG; 6, CAG CTTCCTCTGGAGTAGGGGGGTTCTGCAAGTCTGGTG T; 7, CAACAGTGACCAGAAACGGGCAGAGGAAAATT GCACA; 8, TCTATCCGCCAACAGTACCCCCCGCTTT GCAGTCGAGATA; 9, TATAGTCGACACTGGGGGCAG TACTTAGTGTTC; 10, GTGATAATGACTGGGCTAT GTC; 11, AATACGACTCACTATAGGGGGCAGTACT TAGTGTTCAACAG; 12, AT*CTCGAGGGTACCACCAA T*CCTGTGCGGCTCCAT*A (amino-allyl-modified T residues are marked by asterisks).
###end p 11
###begin title 12
###xml 20 25 <span type="species:ncbi:9606">human</span>
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
###xml 37 40 <span type="species:ncbi:9913">cow</span>
Characterisation of human, mouse and cow U93 RNAs
###end title 12
###begin p 13
###xml 204 206 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c19">19</xref>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sma</italic>
###xml 710 712 710 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c29">29</xref>
###xml 57 62 <span type="species:ncbi:9606">human</span>
###xml 134 139 <span type="species:ncbi:9606">human</span>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 367 370 <span type="species:ncbi:9913">cow</span>
###xml 606 611 <span type="species:ncbi:10090">mouse</span>
###xml 616 619 <span type="species:ncbi:9913">cow</span>
###xml 818 823 <span type="species:ncbi:10090">mouse</span>
###xml 828 831 <span type="species:ncbi:9913">cow</span>
A recombinant plasmid carrying a full-length cDNA of the human U93 scaRNA was identified during characterisation of a cDNA library of human HeLa snRNAs. Synthesis and cloning of cDNAs has been described (19). The 5' terminus of U93 was confirmed by primer extension analysis using the terminally labelled oligonucleotide 1 as a primer. Partial cDNAs of the mouse and cow U93 scaRNAs were obtained by RT-PCR using oligonucleotides 2 and 3 as primers. The PCR-amplified fragments were cloned into the SmaI site of pBluescript (Stratagene) and subjected to sequence analyses. The 3'-terminal sequences of the mouse and cow U93 RNAs were determined by the oligoribonucleotide ligation-PCR amplification procedure (29), except that oligonucleotide 2 was used as a U93-specific upstream primer. The 5'-terminal sequences of mouse and cow U93 RNAs were determined by the RNA 5'-RACE procedure using oligonucleotide 1 as a primer.
###end p 13
###begin title 14
Expression constructs
###end title 14
###begin p 15
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 187 190 187 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Sal</italic>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c30">30</xref>
###xml 530 532 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 552 556 552 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA1</italic>
###xml 910 913 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 919 922 919 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu</italic>
###xml 944 947 944 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 953 956 953 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlu</italic>
###xml 1035 1037 1035 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 1345 1349 1345 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA2</italic>
###xml 1379 1382 1379 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 1388 1391 1388 1391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 1439 1443 1439 1443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA2</italic>
###xml 1594 1596 1594 1596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c31">31</xref>
###xml 1681 1683 1681 1683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
###xml 1281 1286 <span type="species:ncbi:9606">human</span>
###xml 1629 1634 <span type="species:ncbi:9606">human</span>
###xml 1644 1649 <span type="species:ncbi:10090">mouse</span>
The coding region of the human U93 RNA gene was PCR amplified by using oligonucleotides 4 and 5 as primers and human genomic DNA as a template. The PCR product was digested with ClaI and SalI and inserted into the ClaI and XhoI sites of the pCMV-globin expression vector (18), resulting in pCMV-globin-U93. Construction of derivatives of pCMV-globin-U93 carrying U93 genes with altered H1, H2 and ACA1 boxes was performed by the megaprimer amplification approach using pCMV-globin-H93 as a template (30). To obtain pCMV-globin-U93H1 and pCMV-globin-U93ACA1, the 5' half of the U93 gene was amplified with oligonucleotides 6 and 7 as mutagenic 3' primers, respectively, and oligonucleotide 4 as a 5'-end-specific primer. The PCR products were used as megaprimers in the second amplification step in combination with a common 3'-end-specific primer (oligonucleotide 5). The amplified products were digested with ClaI and MluI and cloned into the ClaI and MluI sites of pCMV-globin. A similar strategy was used to generate pCMV-globin-U93H2, except that a megaprimer was generated with oligonucleotides 5 and 8 as 3'- and 5'-end-specific primers, respectively. In the second step of amplification, oligonucleotide 4 was used as a 5'-end-specific primer. Finally, amplification of the human U93 RNA gene with oligonucleotides 4 and 9 resulted in U93ACA2, which was inserted into the ClaI and XhoI sites of pCMV-globin, yielding pCMV-globin-U93ACA2. The identity of each expression construct was verified by sequence analyses. Construction of the coilin-Dsred2 expression vector has been described (31). Transfection of simian COS-7, human HeLa and mouse L929 cells has been described (18).
###end p 15
###begin title 16
Immunoprecipitation, cell fractionation and RNA analysis
###end title 16
###begin p 17
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 323 325 323 325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c32">32</xref>
###xml 523 525 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c33">33</xref>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 596 598 596 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c33">33</xref>
###xml 624 626 624 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 631 635 631 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA1</italic>
###xml 640 642 640 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 650 654 650 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA2</italic>
###xml 728 731 728 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 774 776 774 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 793 797 793 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA1</italic>
###xml 814 816 814 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 836 840 836 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA2</italic>
###xml 918 920 918 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Immunoprecipitation of human snRNPs with anti-fibrillarin and anti-hGAR1 antibodies (kindly provided by Drs J. A. Steitz and W. Filipowicz, respectively) was performed as described (18). Fractionation of HeLa cells into nuclear, nucleoplasmic, nucleolar and cytoplasmic fractions was performed according to Tyc and Steitz (32). From COS-7 and HeLa cells and the nuclear, nucleolar, nucleoplasmic and cytoplasmic fractions of HeLa cells, RNA was isolated by the guanidine thiocyanate/phenol-chloroform extraction procedure (33). RNase A/T1 protection was performed as described by Goodall et al. (33). For mapping of U93, U93H1, U93ACA1, U93H2 and U93ACA2 RNAs, sequence-specific RNA probes were synthesised by SP6 RNA pol using NdeI-digested pCMV-globin-U93, pCMV-globin-U93H1, pCMV-globin-U93ACA1, pCMV-globin-U93H2 and pCMV-globin-U93ACA2 plasmids as templates. Probes for U3, U4 and U19 snRNAs have been described (18). After synthesis, all probes were purified on a 6% sequencing gel.
###end p 17
###begin title 18
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
In situ hybridisation
###end title 18
###begin p 19
###xml 12 19 12 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 471 479 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1081 1083 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
###xml 944 949 <span type="species:ncbi:9606">Human</span>
###xml 993 999 <span type="species:ncbi:9986">rabbit</span>
Fluorescent in situ hybridisation, image acquisition and processing has been described (18). To generate antisense RNA probe for the human U93 RNA, a fragment of the U93 gene from position 159 to position 269 was PCR-amplified with oligonucleotides 10 and 11 as primers. Utilisation of oligonucleotide 11 as a 3'-end-specific primer resulted in inclusion of the T7 RNA polymerase promoter into the amplified fragment. The resulting PCR product was used as a template for in vitro transcription by T7 RNA polymerase in the presence of 5-(3-aminoallyl) uridine 5'-triphosphate. Detection of the 5'-terminal box H/ACA domain of the U93 RNA was performed by using an oligonucleotide probe complementary to the human U93 RNA from position 13 to 44 (oligonucleotide 12). The modified RNA and oligonucleotide probes were labelled with FluoroLinktrade mark Cy5-monofunctional dye (Amersham) according to the protocol of the laboratory of Dr Singer (). Human p80 coilin has been detected by polyclonal rabbit anti-coilin antibody (kindly provided by Dr A. Lamond) as it has been described (18).
###end p 19
###begin title 20
RESULTS
###end title 20
###begin title 21
###xml 43 48 <span type="species:ncbi:9606">human</span>
Identification of a novel Gar1p-associated human box H/ACA RNA
###end title 21
###begin p 22
###xml 178 179 178 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f2">2</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 712 713 712 713 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 46 51 <span type="species:ncbi:9606">human</span>
###xml 162 167 <span type="species:ncbi:9606">human</span>
###xml 550 555 <span type="species:ncbi:9606">human</span>
###xml 682 687 <span type="species:ncbi:9606">human</span>
###xml 992 997 <span type="species:ncbi:9606">human</span>
During sequence analysis of a cDNA library of human HeLa snRNAs, we have identified a 275 nt long RNA that showed no significant sequence similarity to any known human RNA (Fig. 2). Northern analysis and RNase A/T1 protection experiments confirmed that the new RNA, called hereafter as U93, efficiently accumulates in HeLa cells (Figs 3 and 4; data not shown). The presence of an ACA triplet 3 nt before the 3' terminus of the U93 RNA indicated that it might belong to the family of box H/ACA RNAs. Indeed, a monoclonal antibody directed against the human Gar1 protein, a component of box H/ACA RNPs, specifically precipitated the U93 RNA as well as the U19 box H/ACA snoRNA from a human HeLa cell extract (Fig. 3A). In contrast, an anti-fibrillarin antibody failed to precipitate both U93 and U19, but recognised the fibrillarin-associated U3 box C/D snoRNA. As expected, neither the anti-fibrillarin nor the anti-GAR1 antibody reacted with the U4 spliceosomal snRNP, demonstrating that the human U93 RNA specifically associates with the Gar1 snoRNP protein and it belongs to the family of box H/ACA RNAs.
###end p 22
###begin title 23
Mammalian U93 snRNA is composed of two box H/ACA RNA-like domains
###end title 23
###begin p 24
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c34">34</xref>
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f1">1</xref>
###xml 344 345 344 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f2">2</xref>
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 623 628 <span type="species:ncbi:9606">human</span>
Computer modelling was used to generate a secondary structure for the human U93 RNA (34). In contrast to the consensus 'hairpin-hinge-hairpin-tail' structure of box H/ACA snoRNAs (Fig. 1), the computer-predicted structure of U93 is composed of four hairpins connected by three single-stranded hinge regions and terminated by a short tail (Fig. 2). We noticed that the first and third hairpins of U93 are followed by potential box H sequences (63-AAAGCA-68 and 202-AGAGAA-207) and that the second and the last hairpins are followed by potential box ACA motifs (134-AUA-136 and 270-ACA-272). This strongly suggested that the human U93 RNA is composed of two tandemly arranged box H/ACA RNA domains.
###end p 24
###begin p 25
###xml 454 455 454 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f2">2</xref>
###xml 21 26 <span type="species:ncbi:10090">mouse</span>
###xml 28 31 <span type="species:ncbi:10116">rat</span>
###xml 33 36 <span type="species:ncbi:9913">cow</span>
###xml 41 45 <span type="species:ncbi:7962">carp</span>
###xml 76 81 <span type="species:ncbi:9606">human</span>
###xml 156 161 <span type="species:ncbi:9606">human</span>
###xml 217 222 <span type="species:ncbi:10090">mouse</span>
###xml 227 230 <span type="species:ncbi:9913">cow</span>
###xml 405 410 <span type="species:ncbi:9606">human</span>
###xml 412 417 <span type="species:ncbi:10090">mouse</span>
###xml 422 425 <span type="species:ncbi:9913">cow</span>
###xml 850 855 <span type="species:ncbi:9606">human</span>
###xml 857 862 <span type="species:ncbi:10090">mouse</span>
###xml 867 870 <span type="species:ncbi:9913">cow</span>
###xml 1207 1210 <span type="species:ncbi:9913">cow</span>
Northern analysis of mouse, rat, cow and carp nuclear RNAs performed with a human U93-specific antisense RNA probe revealed hybridising RNAs of the size of human U93 (data not shown). The full-length sequences of the mouse and cow U93 RNAs were obtained by RT-PCR followed by 5'- and 3'-end RACE experiments (see Materials and Methods). A comparison of the sequences and two-dimensional structures of the human, mouse and cow U93 RNAs is shown in Figure 2. Strikingly, most of the evolutionarily variable nucleotides are located in predicted single-stranded regions, namely in the three hinge and the 3'-terminal tail regions as well as in internal and terminal loop structures. Contrary to the fact that the hinge regions show the highest sequence variability, nucleotides in the putative H1, H2, ACA1 and ACA2 motifs are perfectly conserved in the human, mouse and cow U93 RNAs, pointing to the functional importance of these sequences. In most cases, altered nucleotides located in double-stranded regions do not interfere with the formation of perfect double helices (see positions U7, A107, A164, A165, A196, G184, G232, A254). Even more tellingly, transition of the A168 residue to a G residue in the cow U93 RNA is restored by a U to C compensatory base change in the opposite strand of the proposed double helix. Taken together, these observations strongly supported the correctness of the proposed secondary structure of U93 and confirmed the conclusion that the mammalian U93 RNA is composed of two box H/ACA snoRNA-like domains.
###end p 25
###begin title 26
###xml 4 9 <span type="species:ncbi:9606">human</span>
The human U93 RNA specifically accumulates in Cajal bodies
###end title 26
###begin p 27
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c8">8</xref>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 453 454 453 454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 723 725 723 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c35">35</xref>
###xml 1139 1140 1139 1140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c8">8</xref>
###xml 1141 1143 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c11">11</xref>
###xml 1144 1146 1144 1146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 1325 1326 1325 1326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 845 850 <span type="species:ncbi:9606">human</span>
Mammalian box H/ACA RNAs accumulate either in the nucleolus or in the nucleoplasmic Cajal bodies (8,18). Upon fractionation of human HeLa cells, the U93 RNA and the U4 spliceosomal snRNA were found mainly in the nucleoplasmic fraction, while the U19 box H/ACA and the U3 box C/D authentic snoRNAs co-purified with the nucleolar fraction (Fig. 3B). To determine the precise nucleoplasmic localisation of U93, we used in situ fluorescent microscopy (Fig. 3C). Probing of HeLa cells with a U93-specific fluorescent antisense RNA probe revealed that the U93 RNA localises to sharp dot-like structures in the nucleoplasm. Staining the same cells with an antibody directed against p80 coilin, a molecular marker of Cajal bodies (35), demonstrated that the U93 RNA perfectly co-localises with p80 coilin. Likewise, upon transient overexpression of the human U93 RNA in HeLa cells (for details, see below), the overproduced U93 RNA showed a specific co-localisation with p80 coilin. Thus far, all box C/D and box H/ACA RNAs residing in Cajal bodies have been implicated in post-transcriptional modification of pol II-specific spliceosomal snRNAs (8,11,18). Indeed, we noticed that sequences in the internal loop of the 3'-terminal hairpin of U93 are capable of positioning the U54 residue in the U2 snRNA for pseudouridylation (Fig. 3D). We concluded that (i) the U93 box H/ACA-H/ACA composite RNA represents a new member of scaRNAs and (ii) the U93 scaRNA likely functions in pseudouridylation of the RNA pol II-specific U2 spliceosomal snRNA.
###end p 27
###begin title 28
Elements essential for accumulation of the U93 box H/ACA-H/ACA scaRNA
###end title 28
###begin p 29
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c14">14</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c15">15</xref>
###xml 476 478 476 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c36">36</xref>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c37">37</xref>
###xml 664 665 661 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 875 876 872 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 66 71 <span type="species:ncbi:4932">yeast</span>
###xml 318 323 <span type="species:ncbi:9606">human</span>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 586 591 <span type="species:ncbi:9606">human</span>
###xml 644 647 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 919 924 <span type="species:ncbi:9606">human</span>
The box H and ACA elements play a crucial role in accumulation of yeast and mammalian box H/ACA snoRNAs (14,15). Since the U93 RNA possesses two putative box H (H1 and H2) and ACA (ACA1 and ACA2) elements, we have tested the functional importance of each of these elements in RNA accumulation. The genomic copy of the human U93 RNA is located in an intron of a series of reported spliced expressed sequence tags, indicating that the U93 RNA is generated by intron processing (36,37). Therefore, to express the human U93 RNA, its coding region was inserted into the second intron of the human beta-globin gene controlled by the cytomegalovirus (CMV) promoter (Fig. 4A). The resulting pCMV-globin-U93 expression construct was transfected into simian COS-7 cells and expression of the U93 RNA was tested by RNase A/T1 mapping using a sequence-specific antisense RNA probe (Fig. 4B, lane 3). As compared with the authentic human U93 RNA (lane 1), the plasmid-born U93 RNA was faithfully processed from the globin pre-mRNA, further supporting the notion that U93 is indeed an intron-encoded RNA.
###end p 29
###begin p 30
###xml 315 316 315 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 605 606 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 806 807 782 783 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 1241 1242 1217 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 1095 1100 <span type="species:ncbi:9606">human</span>
When either the box H1, ACA1, H2 or ACA2 motif of the U93 gene was replaced with a C stretch of appropriate length in the pCMV-globin-U93 construct, accumulation of the full-length U93 RNA was completely abolished in transfected COS-7 cells, although the globin host mRNA was correctly expressed in each case (Fig. 4B, lanes 5, 7, 9 and 11). Upon disruption of the box H1 or ACA1 motif, RNase mapping resulted in accumulation of a protected RNA doublet with a molecular size that corresponds to the predicted length of the processed 3'-terminal box H/ACA domain of the U93 RNA (approximately130 nt) (Fig. 4B, lanes 5 and 7). On the other hand, alteration of the H2 or ACA2 motif resulted in the accumulation of an RNA of the expected size (approximately140 nt) of the 5'-terminal H/ACA domain of U93 (Fig. 4B, lanes 9 and 11). Indeed, the identity of these RNAs was confirmed by RNase mappings performed with probes specific for either the 5'- or the 3'-terminal half of the U93 RNA (data not shown). These results demonstrated that both the 5'- and the 3'-terminal box H/ACA RNA domains of the human U93 RNA can independently accumulate. However, mapping of HeLa cellular RNA failed to detect any accumulating fragment of the U93 RNA (Fig. 4B, lane 1, and data not shown), indicating that normally neither the 5'- nor the 3'-terminal box H/ACA domain of U93 is expressed separately.
###end p 30
###begin p 31
###xml 238 240 238 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 248 250 248 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f5">5</xref>
###xml 150 155 <span type="species:ncbi:10090">Mouse</span>
###xml 409 414 <span type="species:ncbi:10090">mouse</span>
###xml 535 540 <span type="species:ncbi:9606">human</span>
We next investigated whether the 5'- and 3'-terminal domains of the U93 RNA, when they are expressed independently, still accumulate in Cajal bodies. Mouse cells transfected with the pCMV-globin expression construct carrying the U93, U93-H1 or U93-H2 genes were probed with fluorescent antisense probes specific for the 5'- and 3'-terminal domains of the U93 RNA (Fig. 5). The Cajal bodies of the transfected mouse cells were visualised by co-expression of the coilin-Dsred2 fluorescent recombinant protein. Similar to the full-length human U93 RNA, both the 5'- and 3'-terminal box H/ACA domains of the RNA accumulated in Cajal bodies. This demonstrates that both box H/ACA domains of U93 possess functionally active localisation signals which can direct the Cajal body-specific accumulation of the two domains independently of one another.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 30 31 30 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 226 227 226 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f1">1</xref>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 411 412 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 461 463 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f2">2</xref>
###xml 752 757 <span type="species:ncbi:9606">human</span>
###xml 759 764 <span type="species:ncbi:10090">mouse</span>
###xml 769 772 <span type="species:ncbi:9913">cow</span>
Site-specific synthesis of 2'-O-methylated nucleotides and pseudouridines in rRNAs and spliceosomal snRNAs is directed by guide RNAs which can be classified into three structurally and functionally well defined families (Fig. 1). The box C/D RNAs direct 2'-O-methylation and the box H/ACA RNAs guide pseudouridylation of rRNAs and snRNAs. Another minor group of composite box C/D-H/ACA RNAs function both in 2'-O-methylation and pseudouridylation of snRNAs (18,27). In this study, we have identified and characterised a novel type of pseudouridylation guide RNA. The U93 RNA is composed of two tandemly arranged box H/ACA RNA domains and, therefore, it carries two box H and ACA motifs. This unique architecture of the U93 RNA is conserved at least in human, mouse and cow (Fig. 2).
###end p 33
###begin p 34
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
###xml 955 956 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 33 38 <span type="species:ncbi:9606">human</span>
###xml 415 420 <span type="species:ncbi:9606">human</span>
Previous characterisation of the human U85 box C/D-H/ACA composite RNA showed that the unusual structural organisation of this class of modification guide RNAs could be explained by several facts. Alteration of the 5'-terminal C or the 3'-terminal D box of the U85 RNA completely abolished the expression of both the full-length U85 RNA and box H/ACA domain of the RNA (27). This indicated that accumulation of the human U85 box C/D-H/ACA RNA is supported exclusively by its box C/D domain and that the box H/ACA domain of the RNA lacks metabolic stability. In the case of the newly discovered U93 box H/ACA-H/ACA composite RNA, all conserved box elements (H1, ACA1, H2 and ACA2) are required for accumulation of the full-length RNA. However, accumulation of the 5'- and 3'-terminal box H/ACA domains of U93 is not interdependent. In other words, both box H/ACA domains of the U93 RNA possess all those elements which are essential for accumulation (Fig. 4).
###end p 34
###begin p 35
###xml 17 18 17 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 217 219 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 270 273 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 883 884 883 884 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f5">5</xref>
###xml 452 457 <span type="species:ncbi:9606">human</span>
###xml 690 695 <span type="species:ncbi:9606">human</span>
Thus far, all 2'-O-methylation and pseudouridylation guide RNAs implicated in modification of the RNA pol II-specific U1, U2, U4 and U5 spliceosomal snRNAs have been found to reside in the nucleoplasmic Cajal bodies (18). It seems that these guide RNAs possess specific cis-acting targeting elements which are responsible for the their Cajal body specific localisation. Currently, we have found that the Cajal body-specific localisation signals of the human U85 C/D-H/ACA scaRNA are located in the box H/ACA domain of the RNA and that the box C/D domain of U85 alone cannot localise to Cajal bodies (P.Richard, X.Darzacq, C.Verheggen, E.Bertrand and T.Kiss, manuscript in preparation). The human U93 box H/ACA-H/ACA RNA also accumulates in Cajal bodies and, unexpectedly, both box H/ACA domains of the U93 RNA possess functionally active Cajal body-specific targeting elements (Fig. 5). So, in contrast to the U85 box C/D-H/ACA RNA, the unusual structural organisation of the U93 box H/ACA-H/ACA RNA cannot be explained by the metabolic instability or incorrect intracellular trafficking of the two domains of the RNA.
###end p 35
###begin p 36
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
###xml 461 462 461 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c23">23</xref>
###xml 579 581 579 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c38">38</xref>
###xml 916 917 916 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f2">2</xref>
The box C/D and H/ACA domains of the U85 RNA function in 2'-O-methylation and pseudouridylation of two neighbouring nucleotides in the U5 spliceosomal snRNA. This suggests that co-expression of guide RNAs directing modification of the same substrate RNA is advantageous for the cell (27). The putative pseudouridylation pocket in the 3'-terminal hairpin of the U93 RNA is predicted to direct pseudouridylation of the U2 spliceosomal snRNA at position U54 (Fig. 3D). Since both the 5'- and 3'-terminal hairpins of box H/ACA RNAs can carry functional pseudouridylation pockets (23,38), the four hairpins of the U93 box H/ACA-H/ACA RNA, in principle, could direct pseudouridylation of four different substrate uridines. It seems, however, unlikely that the first and third hairpins of U93 contain functional pseudouridylation pockets, since several evolutionarily altered nucleotides are present in these regions (Fig. 2). On the contrary, the second hairpin carries a conserved internal loop that possesses the characteristic topology of a functional pseudouridylation pocket. This putative pseudouridylation pocket of U93 lacks complementarity to rRNAs, spliceosomal snRNAs or any known stable RNAs, including tRNAs. Therefore, it seems likely that the second hairpin of the U93 RNA directs pseudouridylation of a not yet identified RNA. Whether this putative target RNA of U83, like all substrate RNAs of Cajal body-specific guide RNAs, has a cellular function related to pre-mRNA splicing remains an intriguing speculation.
###end p 36
###begin p 37
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c18">18</xref>
###xml 263 265 263 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c27">27</xref>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c39">39</xref>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="gkf592c40">40</xref>
###xml 287 292 <span type="species:ncbi:4932">yeast</span>
In summary, identification of the U93 RNA that is composed of two box H/ACA RNA domains further supports the idea that snRNA structural domains are frequently used to build novel composite RNAs. In addition to the recently characterised box C/D-H/ACA scaRNAs (18,27), the vertebrate and yeast telomerase RNAs carry a box H/ACA and Sm domain, respectively (39,40). In principle, acquisition of a structurally and functionally well defined snRNA domain may contribute to metabolic stability, may direct intracellular trafficking or may provide a new cellular function for the newly made composite RNA.
###end p 37
###begin title 38
Figures and Tables
###end title 38
###begin p 39
###xml 22 23 22 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 153 154 153 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">O</italic>
 Classification of 2'-O-methylation and pseudouridylation guide RNAs. Schematic representation of the consensus two-dimensional structures of box C/D 2'-O-methylation, box H/ACA pseudouridylation and box C/D-H/ACA composite 2'-O-methylation and pseudouridylation guide RNAs. Positions of the conserved box elements are indicated.
###end p 39
###begin p 40
###xml 234 246 234 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mus musculus</italic>
###xml 257 267 257 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Bos taurus</italic>
###xml 53 58 <span type="species:ncbi:9606">human</span>
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
###xml 70 73 <span type="species:ncbi:9913">cow</span>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 227 232 <span type="species:ncbi:10090">mouse</span>
###xml 234 246 <span type="species:ncbi:10090">Mus musculus</span>
###xml 252 255 <span type="species:ncbi:9913">cow</span>
###xml 257 267 <span type="species:ncbi:9913">Bos taurus</span>
###xml 584 589 <span type="species:ncbi:9606">human</span>
 Primary and predicted two-dimensional structures of human, mouse and cow U93 box H/ACA-H/ACA RNAs. The nucleotide sequence of the human U93 RNA is in capitals. Lower case and circled lower case letters indicate changes in the mouse (Mus musculus) and cow (Bos taurus) U93 RNAs, respectively. Nucleotide deletions (Delta) and insertions (arrowheads) are also indicated. The putative box H (H1 and H2) and ACA (ACA1 and ACA2) sequences are boxed. Please note that nucleotides which might be involved in formation of putative pseudouridylation pockets are unfolded. The sequence of the human U93 RNAs is available in GenBank under the accession no. AF492209.
###end p 40
###begin p 41
###xml 37 38 37 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 424 440 416 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 513 516 505 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hea</italic>
###xml 525 528 517 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Taq</italic>
###xml 549 550 541 542 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 791 792 783 784 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 794 801 786 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 953 954 945 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 1397 1398 1389 1390 <bold xmlns:xlink="http://www.w3.org/1999/xlink">D</bold>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 260 265 <span type="species:ncbi:9606">human</span>
###xml 424 440 <span type="species:ncbi:562">Escherichia coli</span>
###xml 827 832 <span type="species:ncbi:9606">Human</span>
###xml 1019 1024 <span type="species:ncbi:9606">human</span>
###xml 1093 1098 <span type="species:ncbi:9606">human</span>
###xml 1442 1447 <span type="species:ncbi:9606">human</span>
 Characterisation of human U93 RNA. (A) Immunological characterisation of U93 RNP. RNAs recovered from the pellet of immunoprecipitation reactions performed with anti-hGAR1 (alpha-Gar), anti-fibrillarin (alpha-Fib) or a control non-immune serum (Nonim) from a human HeLa cell extract were mapped with sequence-specific antisense RNA probes indicated on the right. Lanes C and E show control mappings with RNAs obtained from Escherichia coli and HeLa cell extracts, respectively. Lane M, size marker (a mixture of HeaIII- and TaqI-digested pBR322). (B) Cell fractionation. RNA isolated from HeLa cells (T), from the nuclear (Nu), nucleoplasmic (Np), nucleolar (No) and cytoplasmic (Cy) fractions of HeLa cells were mapped by sequence-specific antisense RNA probes as indicated on the right. (C) In situ localisation of U93 RNA. Human HeLa cells either transfected (bottom) or non-transfected (top) with the pCMV-globin-U93 expression construct (see Fig. 4A) were probed with a fluorescent RNA probe complementary to the human U93 RNA. Cajal bodies were detected by an antibody directed against human p80 coilin. Merged images show that the U93 RNA co-localises with p80 coilin both in transfected and non-transfected cells. The nuclei of non-transfected cells are highlighted by dotted lines. Under the exposure conditions shown, the endogenous U93 RNA remains invisible in non-transfected cells. (D) Potential base-pairing interaction of the human U93 and U2 RNAs. The 3'-terminal hairpin of U93 is schematically indicated. The U54 residue known to be pseudouridylated in vertebrate U2 snRNAs is indicated (Psi).
###end p 41
###begin p 42
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 382 383 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 385 388 382 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nde</italic>
###xml 391 392 388 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H</italic>
###xml 394 397 391 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hin</italic>
###xml 403 404 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 406 409 403 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cla</italic>
###xml 416 417 413 414 <italic xmlns:xlink="http://www.w3.org/1999/xlink">X</italic>
###xml 419 422 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Xho</italic>
###xml 494 496 491 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 502 506 499 503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA1</italic>
###xml 512 514 509 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 523 527 520 524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ACA2</italic>
###xml 609 610 606 607 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 25 30 <span type="species:ncbi:9606">human</span>
###xml 129 132 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 297 303 <span type="species:ncbi:9913">bovine</span>
###xml 468 473 <span type="species:ncbi:9606">human</span>
 Transient expression of human U93 RNA in COS-7 cells. (A) Schematic representation of the pCMV-globin expression construct. The CMV promoter, full-length (E1 and E2) and partial (E3) exons of the human beta-globin gene, the SP6 RNA polymerase promoter (SP6) and the polyadenylation region of the bovine growth hormone gene (PA) are indicated. Relevant restriction sites are shown (N, NdeI; H, HindIII; C, ClaI; and X, XhoI). Open arrow indicates the coding region of human U93 RNA. In the U93-H1, U93-ACA1, U93-H2 and U93-ACA2 constructs, the indicated box element was replaced for a stretch of C residues. (B) RNase A/T1 protection analysis. Plasmids used for transfection of COS-7 cells and specific probes utilised for mappings are indicated at the top. Lanes N and T represent mapping reactions with RNAs obtained from non-transfected and transfected cells, respectively. Lane H, mapping of HeLa cellular RNAs. RNA fragments protected by the first and second exons of the spliced beta-globin mRNA, the U93 RNA and the 5'- and 3'-terminal portions of the U93 RNA are indicated on the right. Lane M, size marker in nucleotides.
###end p 42
###begin p 43
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ</italic>
###xml 180 182 180 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H1</italic>
###xml 202 204 202 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H2</italic>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f4">4</xref>
###xml 575 576 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="gkf592f3">3</xref>
###xml 69 74 <span type="species:ncbi:9606">human</span>
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
###xml 105 110 <span type="species:ncbi:10090">Mouse</span>
###xml 401 406 <span type="species:ncbi:9606">human</span>
###xml 446 451 <span type="species:ncbi:10090">mouse</span>
In situ localisation of the 5'- and 3'-terminal box H/ACA domains of human U93 expressed in mouse cells. Mouse L929 cells were transfected with the pCMV-globin-U93, pCMV-globin-U93H1 and pCMV-globin-U93H2 expression constructs (see Fig. 4A). The transiently expressed U93 RNA was visualised by a fluorescent oligonucleotide or an antisense RNA probe specific for the 5'- and 3'-terminal domain of the human U93 RNA, respectively. Cajal bodies of mouse cells were detected by co-expression of the coilin-Dsred2 fluorescent protein. For other details, see the legend to Figure 3C.
###end p 43
###begin title 44
ACKNOWLEDGEMENTS
###end title 44
###begin p 45
We are indebted to Y. de Preval for synthesis of oligonucleotides. A.M.K. was funded by the French Government and the Hungarian Academy of Sciences. B.E.J. is a recipient of a long term EMBO fellowship. X.D. and C.V. were funded by la Fondation pour la Recherche Medicale and Association pour la Recherche contre le Cancer, respectively. Our work was supported by grants from Association pour la Recherche contre le Cancer, la Ligue Nationale contre le Cancer, the French MNRT (ACI) and the Hungarian Research Foundation (OTKA, T29042 and T31738).
###end p 45
###begin title 46
REFERENCES
###end title 46

